How good is the evidence to support primary care practice?

Mark H Ebell, Randi Sokol, Aaron Lee, Christopher Simons, Jessica Early

10.1136/ebmed-2017-110704

May 29, 2017

Editor's choice

New evidence pyramid

M Hassan Murad, Noor Asi, Mouaz Alsawas, Fares Alahdab

10.1136/ebmed-2016-110401

June 23, 2016

Evidence-Based Medicine these 7 years: time for the editor to go on permanent sabbatical

Richard Saitz

10.1136/ebmed-2017-110705

April 20, 2017

Editor's choice

Rating the certainty in evidence in the absence of a single estimate of effect

M Hassan Murad, Reem A Mustafa, Holger J Schünemann, Shahnaz Sultan, Nancy Santesso

10.1136/ebmed-2017-110668

March 20, 2017

Grading evidence from test accuracy studies: what makes it challenging compared with the grading of effectiveness studies?

Ewelina Rogozińska, Khalid Khan

10.1136/ebmed-2017-110717

June 9, 2017

Editor's choice

Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes

Denise Campbell-Scherer

10.1136/ebmed-2017-110685

March 8, 2017

Editor's choice

Evidence-based medicine: a persisting desire under fire

Fares Alahdab, Samer Alabed, Ahmed Al-Moujahed, Mohammad Anass Al Sallakh, Tareq Alyousef, Ubai Alsharif, Munes Fares, M Hassan Murad

10.1136/ebmed-2016-110608

December 13, 2016

Editor's choice

Grading the quality of evidence in complex interventions: a guide for evidence-based practitioners

M Hassan Murad, Jehad Almasri, Mouaz Alsawas, Wigdan Farah

10.1136/ebmed-2016-110577

December 8, 2016

Editor's choice

EBHC pyramid 5.0 for accessing preappraised evidence and guidance

Brian S Alper, R Brian Haynes

10.1136/ebmed-2016-110447

June 20, 2016

Editor's choice

Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes

Denise Campbell-Scherer

10.1136/ebmed-2016-110652

March 7, 2017

Editor's choice